Search Tag: Hologic

Hologic 3D Mammography Workshop: Advanced Case Review

2016 15 Feb

Hologic is offering a series of 90-minute educational sessions for radiologists throughout the ECR Congress. Prior to the hands-on, a brief lecture will be provided by a radiologist pioneer in the clinical use of 3D Mammography™, who will present an overview of the technology and reading principles of tomosynthesis.  This program is intended for radiologists... Read more

Hologic Innovation Workshop: Breast Biopsy

2016 15 Feb

Hologic is offering a series of 45-minute educational sessions for radiologists. A brief lecture will provide an overview of the clinical experiences with vacuum breast biopsies guided by 3D Imaging, prior to a demonstration of a phantom procedure using live imaging supervised by radiation protection services.  This program is intended for radiologists... Read more

Hologic Innovation Workshop: Advanced Densitometry

2016 15 Feb

Hologic is offering a series of 45-minutes educational sessions for radiologists. A brief lecture will provide an overview of the clinical experiences of imaging and new quantification applications of DXA.  This program is intended for radiologists interested in learning more about new application based on the Hologic DXA technology. Date... Read more

Hologic to Webcast Presentations at Upcoming Investor Conferences

2016 03 Feb

Hologic, Inc. has announced that the Company will present at these upcoming investor conferences: The LEERINK Partners 5 th  Annual Global Healthcare Conference in  New York, NY  on  Wednesday, February 10  at  3:05 pm Eastern Time  (ET). The RBC Capital Markets 2016 Global Healthcare Conference in  New York, NY  on  Tuesday, Febr Read more

Hologic Delivers Notice that Holders of 2.00% Converts Due 2037 are Eligible to Convert

2016 05 Jan

Hologic, Inc. has announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010, and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes.  This conversion right is subject to the terms of... Read more

Hologic to Announce Financial Results for the First Quarter of Fiscal 2016 on January 27, 2016

2016 04 Jan

Hologic, Inc. has announced that the Company plans to release its financial results for the first quarter of fiscal 2016 on  Wednesday, January 27, 2016 , after the market closes.  In conjunction with the release, management will host a conference call that day at  4:30 p.m. Eastern Time . Interested participants may listen to the call by dialing... Read more

Hologic Applauds Passage of Federal Measures that Preserve Access to Breast Cancer Screening

2015 22 Dec

Hologic, Inc. has expressed support for new federal measures that preserve access to mammography for breast cancer screening and increase incentives for biomedical research and development.  These measures were recently passed with bipartisan Congressional support and signed into law by the President. Essential components of the Protect Access to... Read more

Hologic to Present at the 34th Annual J.P. Morgan Healthcare Conference

2015 21 Dec

Hologic, Inc. has announced that the Company will present at the 34th Annual J.P. Morgan Healthcare Conference in  San Francisco  on  January 12, 2016  at  2 p.m. Pacific Time . The presentation will be webcast live and may be accessed through a link on the investors section of Hologic's website at  http://investors.hologic.com .  The webcast will... Read more

Hologic Launches First Fully Automated, Sample-to-Result Molecular Assay in Europe

2015 16 Dec

-- The CE-marked Aptima® Mycoplasma genitalium Assay on the Panther® System Identifies a Prevalent, Often Misdiagnosed Sexually Transmitted Infection --   Hologic, Inc. has announced the European launch of the CE-marked Aptima Mycoplasma genitalium assay, adding to the growing menu of molecular tests available on the fully automated Panther system.... Read more

Hologic Expands its European Virology Portfolio with CE-IVD Certified Assay for HBV Viral Load

2015 10 Dec

-- Aptima® HBV Quant Assay Joins Tests for HIV-1 and HCV on the Fully Automated Panther Instrument -- Hologic, Inc. has earned CE-IVD certification for its Aptima HBV Quant assay on the fully automated Panther® instrument, the Company has announced.   This assay expands the European virology menu available on the Panther system, which previously... Read more